Showing 1,641 - 1,660 results of 32,205 for search '(( a step decrease ) OR ( 50 ((teer decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 0.98s Refine Results
  1. 1641

    High-throughput drug screen reveals HDAC and proteasome inhibitors as potent drug classes against synovial sarcoma. by Aimée N. Laporte (3617987)

    Published 2017
    “…<p>(A) Compounds resulting in measured relative cell viability of less than 50% are annotated as hits (blue). …”
  2. 1642
  3. 1643

    Lysine 50 of Tat regulates expression of C5, CRLF2, APBA1, and BDNF genes. by Loreto Carvallo (4167607)

    Published 2017
    “…<p>THP-1Tat-Flag and THP-1Tat K50ATat-Flag cell lines (generated from independent experiments described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0179882#pone.0179882.g005" target="_blank">Fig 5</a>) were differentiated to macrophages with PMA for 24 and 48 hours. …”
  4. 1644
  5. 1645
  6. 1646
  7. 1647
  8. 1648

    HDAC inhibition prevents aggresome formation in response to proteasome inhibitors, and combination treatment leads to endoplasmic reticulum stress. by Aimée N. Laporte (3617987)

    Published 2017
    “…<p>(A) Knockdown of HDAC6 results in decreased levels of LC3B in the SYO-1 synovial sarcoma cell line. …”
  9. 1649
  10. 1650
  11. 1651
  12. 1652
  13. 1653

    DataSheet1_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du... by Joshua R. Tacca (18067213)

    Published 2024
    “…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”
  14. 1654

    DataSheet4_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du... by Joshua R. Tacca (18067213)

    Published 2024
    “…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”
  15. 1655

    DataSheet3_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du... by Joshua R. Tacca (18067213)

    Published 2024
    “…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”
  16. 1656

    DataSheet2_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du... by Joshua R. Tacca (18067213)

    Published 2024
    “…People with TTA using a stance-phase powered prosthesis (e.g., BiOM, Ottobock, Duderstadt, Germany) walk with increased AL<sub>trail</sub> W<sub>pos</sub> and potentially decreased magnitude of UL<sub>lead</sub> W<sub>neg</sub> compared to a passive-elastic prosthesis. …”
  17. 1657
  18. 1658
  19. 1659
  20. 1660